{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:47:29Z","timestamp":1787068049569,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.urolonc.2025.12.011","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:13:00Z","timestamp":1767946380000},"page":"110975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Location matters: Reduced detection of csPCa in transition zone versus peripheral zone PI-RADS lesions"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9916-4598","authenticated-orcid":false,"given":"Andrew M.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina L.","family":"Noyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Bullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajit","family":"Khooblall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Moriarity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Benidir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane K.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyad","family":"Schwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Haywood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei S.","family":"Purysko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Weight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2025.12.011_bib0001","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.urolonc.2025.12.011_bib0002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.urpr.2017.03.009","article-title":"Prostate multiparametric Magnetic resonance imaging program implementation and impact: initial clinical experience in a community based health system","volume":"5","author":"Farrell","year":"2018","journal-title":"Urol Pract"},{"issue":"2","key":"10.1016\/j.urolonc.2025.12.011_bib0003","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2214\/AJR.13.11046","article-title":"Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis","volume":"202","author":"de Rooij","year":"2014","journal-title":"Am J oentgenol"},{"issue":"3","key":"10.1016\/j.urolonc.2025.12.011_bib0004","first-page":"328","article-title":"MR imaging in local staging of prostate cancer","volume":"63","author":"F\u00fctterer","year":"2007","journal-title":"Eur JRadiol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.12.011_bib0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1148\/radiol.11091822","article-title":"Prostate cancer: multiparametric MR imaging for detection, localization, and staging","volume":"261","author":"Hoeks","year":"2011","journal-title":"Radiology"},{"issue":"19","key":"10.1016\/j.urolonc.2025.12.011_bib0006","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"PRECISION study group collaborators. MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.urolonc.2025.12.011_bib0007","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamaoncol.2020.7589","article-title":"Comparison of multiparametric magnetic resonance imaging-targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial","volume":"7","author":"Klotz","year":"2021","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.12.011_bib0008","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.12.011_bib0009","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS Prostate Imaging - Reporting and Data System: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2025.12.011_bib0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.12.011_bib0011","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1148\/radiol.2015142856","article-title":"Computer-extracted features can distinguish noncancerous confounding disease from prostatic adenocarcinoma at multiparametric MR imaging","volume":"278","author":"Litjens","year":"2016","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.urolonc.2025.12.011_bib0012","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.euf.2018.09.002","article-title":"Perceptions of prostate MRI and fusion biopsy of radiation oncologists and urologists for patients diagnosed with prostate cancer: results from a national survey","volume":"6","author":"Bukavina","year":"2020","journal-title":"Eur Urol Focus"},{"issue":"5","key":"10.1016\/j.urolonc.2025.12.011_bib0013","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.juro.2008.01.017","article-title":"Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features","volume":"179","author":"Cohen","year":"2008","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2025.12.011_bib0014","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/PAS.0000000000000642","article-title":"International society of urological pathology (ISUP) grading of prostate cancer","volume":"40","author":"Egevad","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2025.12.011_bib0015","series-title":"R: a language and environment for statistical computing","year":"2023"},{"issue":"3","key":"10.1016\/j.urolonc.2025.12.011_bib0016","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.juro.2017.03.131","article-title":"Prospective evaluation of PI-RADS\u2122 Version 2 using the International Society of Urological Pathology Prostate Cancer Grade Group System","volume":"198","author":"Mehralivand","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.12.011_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72544-z","article-title":"Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer","volume":"10","author":"Rudolph","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.urolonc.2025.12.011_bib0018","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pros.22903","article-title":"Biologic differences between peripheral and transition zone prostate cancer","volume":"75","author":"Lee","year":"2015","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.urolonc.2025.12.011_bib0019","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiol.10100021","article-title":"Prostate cancer: differentiation of Central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging","volume":"257","author":"Oto","year":"2010","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.urolonc.2025.12.011_bib0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1148\/radiology.190.2.7506836","article-title":"Benign prostatic hyperplasia: value of MR imaging for determining histologic type","volume":"190","author":"Ishida","year":"1994","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.urolonc.2025.12.011_bib0021","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1148\/radiol.2018180123","article-title":"Organized chaos: does PI-RADS Version 2 work in the transition zone?","volume":"288","author":"Weinreb","year":"2018","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.urolonc.2025.12.011_bib0022","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pros.22903","article-title":"Biologic differences between peripheral and transition zone prostate cancer","volume":"75","author":"Lee","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2025.12.011_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109071","article-title":"Optimizing size thresholds for detection of clinically significant prostate cancer on MRI: peripheral zone cancers are smaller and more predictable than transition zone tumors","volume":"129","author":"Mahjoub","year":"2020","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.12.011_bib0024","doi-asserted-by":"crossref","first-page":"42","DOI":"10.23736\/S2724-6051.22.04932-1","article-title":"Comparison of prostate cancer detection rate at targeted biopsy of hub and spoke centers mpMRI: experience matters","volume":"75","author":"Droghetti","year":"2023","journal-title":"Minerva Urol Nephrol"},{"issue":"6","key":"10.1016\/j.urolonc.2025.12.011_bib0025","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","article-title":"The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric Magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study","volume":"80","author":"Emmett","year":"2021","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.12.011_bib0026","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.euo.2022.04.006","article-title":"Diagnostic performance of prostate-specific membrane antigen positron emission tomography-targeted biopsy for detection of clinically significant prostate cancer: a systematic review and meta-analysis","volume":"5","author":"Kawada","year":"2022","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.12.011_bib0027","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00345-022-04243-5","article-title":"Investigating PSMA-PET\/CT to resolve prostate MRI PIRADS4-5 and negative biopsy discordance","volume":"41","author":"Wong","year":"2023","journal-title":"World J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925004946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:29:56Z","timestamp":1773973796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925004946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1078143925004946"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.12.011","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Location matters: Reduced detection of csPCa in transition zone versus peripheral zone PI-RADS lesions","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110975"}}